Overview

BNP Therapy Observation Unit Outcomes STudy (BOOST)

Status:
Terminated
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that patients admitted to an emergency department (ED) observation unit will have a decreased rate of hospital admissions and ED recidivism when treated with nesiritide versus standard therapy. The investigators also hypothesize that decreasing B-type Natriuretic Peptide (BNP) levels during treatment in an ED observation unit will predict improved patient outcomes.
Phase:
Phase 4
Details
Lead Sponsor:
Emory University
Collaborator:
Scios, Inc.
Treatments:
Natriuretic Peptide, Brain